LEADER 01939nam  2200361   450 
001 9910688194103321
005 20230626113429.0
035   $a(CKB)5580000000514272
035   $a(NjHacI)995580000000514272
035   $a(EXLCZ)995580000000514272
100   $a20230626d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aInsights on Antimicrobial Peptides /$fedited by Shymaa Enany, Jorge Masso-Silva and Anna Savitskaya
210  1$aLondon, United Kingdom :$cIntechOpen,$d2022.
215   $a1 online resource (166 pages)
311   $a1-83969-715-6 
330   $aModern medicine is impossible without antibiotics, but global antibiotic usage has led to the development of increasing numbers of multi-drug resistant (MDR) bacteria. Thus, we still have problems with infectious disease treatment despite an arsenal of antibiotics. This has forced researchers to develop new drugs that will be effective against resistant bacteria. Some of these prospective molecules are antimicrobial peptides (AMPs), which are an important component of the innate immune system of various organisms in nature. Currently, more than 3,000 AMPs have been reported with different activities against different bacterial species including resistant phenotype bacteria. AMPs display remarkable structural and functional diversity that is not completely understood. As such, this book presents a comprehensive overview of AMPs and their mechanism of action against MDR bacteria.
606   $aPeptide antibiotics
615  0$aPeptide antibiotics.
676   $a615.1
702   $aSavitskaya$b Anna
702   $aMasso-Silva$b Jorge
702   $aEnamy$b Shymaa
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688194103321
996   $aInsights on Antimicrobial Peptides$92994225
997   $aUNINA